01Feb 2021 by Melissa Slogan
WHAT IS AT STAKE IN EU’S MOVE TO CONTROL VACCINE EXPORTS

WHAT IS AT STAKE IN EU’S MOVE TO CONTROL VACCINE EXPORTS

News
WEEKLY COVID VACCINE RESEARCH UPDATE MONDAY, FEBRUARY 1, 2021 [caption id="attachment_1474" align="alignnone" width="329"] Source: © WHO / Gregor Donaldson[/caption] Data Updates High-income country confirmed dose total: 4.2 billion Upper-middle-income country total: 1.2 billion Lower-middle-income country total: 524 million Low-income country total: 670 million COVAX total: 1.11 billion Total worldwide confirmed purchases of Covid-19 vaccines: 7.2 billion doses Weekly Insights and Interesting Trends Author: Andrea Taylor What is at Stake in EU’s Move to Control Vaccine Exports AstraZeneca recently alerted the EU that it would only be able to deliver 25% of the 80-100 million doses of Covid-19 vaccine expected this quarter, due to production problems in the European plants. The EU responded by suggesting, in the firmest of tones, that AstraZeneca divert doses from the (recently Brexited) UK manufacturing plants…
Read More
25Jan 2021 by Melissa Slogan
THE US FORMALLY JOINED COVAX. WILL IT MATTER?

THE US FORMALLY JOINED COVAX. WILL IT MATTER?

News
WEEKLY COVID VACCINE RESEARCH UPDATE MONDAY, JANUARY 25, 2021 Data Updates High-income country confirmed dose total: 4.2 billion Upper-middle-income country total: 1.14 billion Lower-middle-income country total: 444 million Low-income country total: 270 million COVAX total: 1.11 billion Total worldwide confirmed purchases of Covid-19 vaccines: 7.2 billion doses Weekly Insights and Interesting Trends Author: Andrea Taylor The US formally joined COVAX. Will it Matter? Dr. Anthony Fauci, newly named the US Chief Medical Advisor, warmly addressed the WHO executive board within the first 24 hours of the Biden administration. Dr. Fauci confirmed that under President Joe Biden, the US will rejoin the WHO and will also join COVAX, the global mechanism designed to ensure equitable allocation of vaccines across the world. The value of this move may be largely symbolic at this point. The…
Read More
19Jan 2021 by Melissa Slogan
DIRECT COVID VACCINE DEALS BY POORER COUNTRIES ARE AN IMPORTANT AND ENCOURAGING DEVELOPMENT

DIRECT COVID VACCINE DEALS BY POORER COUNTRIES ARE AN IMPORTANT AND ENCOURAGING DEVELOPMENT

News
WEEKLY COVID VACCINE RESEARCH UPDATE TUESDAY, JANUARY 19, 2021 Data Updates High-income country confirmed dose total: 4.2 billion Upper-middle-income country total: 1.12 billion Lower-middle-income country total: 411 million Low-income country total: 270 million COVAX total 1.07 billion Total worldwide confirmed purchases of Covid-19 vaccines: 7.4 billion doses Weekly Insights and Interesting Trends Author: Andrea Taylor Direct deals by poorer countries are an important and encouraging development This past week, we saw the first direct vaccine purchases made for low-income countries with the African Union’s purchase of 270 million doses of Covid-19 vaccines from Pfizer-BioNTech, OxfordAstraZeneca, and Johnson & Johnson (J&J). A relatively modest purchase of 270 million doses, when 7 billion doses have already been bought, might be overlooked but it actually represents a significant shift in the global power…
Read More
11Jan 2021 by Melissa Slogan
CHANGING HOW INDIA’S VACCINE NUMBERS ARE REPRESENTED IN OUR DATA

CHANGING HOW INDIA’S VACCINE NUMBERS ARE REPRESENTED IN OUR DATA

News
WEEKLY COVID VACCINE RESEARCH UPDATE MONDAY, JANUARY 11, 2021 Data Updates High-income country confirmed dose total: 4.2 billion Upper-middle-income country total: 1.24 billion Lower-middle-income country total: 495 million Low-income country total: 0 COVAX total: 1.07 billion Total worldwide confirmed purchases of Covid-19 vaccines: 7 billion doses Weekly Insights and Interesting Trends Author: Andrea Taylor Changing how India's vaccine numbers are represented in our data We have changed this week the way that India’s reserved doses of vaccine are represented in our data, moving the majority of the doses out of “confirmed” to “potential” doses. The way we have been counting India’s numbers in past weeks is a bit different than for other countries. Our numbers typically come from publicly reported purchases by governments (and occasionally private sector buyers). But because…
Read More
18Dec 2020 by Melissa Slogan
TRACKING COVID VACCINE REGULATORY APPROVALS AROUND THE WORLD

TRACKING COVID VACCINE REGULATORY APPROVALS AROUND THE WORLD

News
WEEKLY COVID VACCINE RESEARCH UPDATE FRIDAY, DECEMBER 18, 2020 Data Updates High-income country confirmed dose total: 4 billion Upper-middle-income country total: 1.1 billion Lower-middle-income country total: 1.8 billion Low-income country total: 0 COVAX total: 870 million Total worldwide confirmed purchases of Covid-19 vaccines: 7.7 billion doses Weekly Insights and Interesting Trends Author: Andrea Taylor Tracking regulatory approvals around the world We have seen a lot of movement in regulatory approval of Covid-19 vaccines over the past two weeks, as vaccination campaigns begin to roll out. When tracking the Covid-19 vaccine landscape, it is important to keep in mind the difference between emergency use authorization and full authorization. Most Covid-19 vaccine approvals received thus far have been limited to emergency use. This may be granted to address a health emergency, on…
Read More
14Dec 2020 by Melissa Slogan
WHAT ARE THE LATEST DEVELOPMENTS WITH VACCINES DEVELOPED IN RUSSIA AND CHINA?

WHAT ARE THE LATEST DEVELOPMENTS WITH VACCINES DEVELOPED IN RUSSIA AND CHINA?

News
WEEKLY COVID VACCINE RESEARCH UPDATE MONDAY, DECEMBER 14, 2020 Data Updates High-income country confirmed dose total: 3.9 billion Upper-middle-income country total: 1 billion Lower-middle-income country total: 1.8 billion Low-income country total: 0 COVAX total: 700 million Total worldwide confirmed purchases of Covid-19 vaccines: 7.4 billion doses Weekly Insights and Interesting Trends Author: Andrea Taylor What are the latest developments with vaccines developed in Russia and China? We are frequently asked why some data about vaccines purchased by Russia and China appear to be missing from our data. The answer is because both countries control largely state-owned vaccine development and manufacturing chains, and, in part because of this, are notably less transparent than some other countries about advance purchases for domestic use as well as exports. Our dataset includes publicly announced…
Read More
13Dec 2019 by Melissa Slogan
USAID Philippines ReachHealth Project: Innovation Scouting Report

USAID Philippines ReachHealth Project: Innovation Scouting Report

Our Reports
USAID’s ReachHealth Project aims to respond to the unmet need for family planning (FP) in the Philippines that has led to high levels of teenage pregnancy, by improving FP knowledge on the individual, household, and community levels; increasing access to comprehensive quality care, increasing provider capacity to deliver comprehensive, quality, and respectful care; strengthening health systems; increasing demand for FP and MNH services; and transforming gender norms. The ReachHealth Project, in partnership with the Duke Global Health Innovation Center (GHIC), in order to achieve sustainability across the intersection of the project’s goals to increase healthy behaviors in underserved populations; increase access to care; and bolster health systems on the local, regional, and national levels, will include a Grand Challenge that, through the provision of grants, individualized mentorship, and strategic connections,…
Read More